GSC 02874
Alternative Names: GSC-02874Latest Information Update: 31 Oct 2025
At a glance
- Originator GeneScience Pharmaceuticals
- Class Small molecules
- Mechanism of Action SLC6A19 protein inhibitors
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Phenylketonuria